Physician profile
Miley W Walker
NPI 1386600062
$1,000.25
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $27.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $403.06 | 2019 | |
| Pfizer INC. | $101.10 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Dendreon Pharmaceuticals LLC | $64.23 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.68 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $52.44 | 2019 | |
| Janssen Biotech, INC. | $41.39 | 2019-2020 | |
| Olympus America INC. | $32.02 | 2019-2020 | |
| Amgen INC. | $31.19 | 2019 | |
| Endo Pharmaceuticals INC. | $27.28 | 2019 | |
| Ferring Pharmaceuticals INC. | $27.14 | 2019 | |
| Rochester Medical Corporation | $18.25 | 2019 | |
| Boston Scientific Corporation | $16.06 | 2019 | |
| Coloplast Corp | $12.51 | 2019 | |
| Neotract INC. | $10.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miley Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.